These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8400233)

  • 1. Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.
    Massaia M; Attisano C; Peola S; Montacchini L; Omedé P; Corradini P; Ferrero D; Boccadoro M; Bianchi A; Pileri A
    Blood; 1993 Sep; 82(6):1787-97. PubMed ID: 8400233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells.
    Bianchi A; Montacchini L; Barral P; Borrione P; Attisano C; Orsini E; Boccadoro M; Pileri A; Massaia M
    Br J Haematol; 1995 Jul; 90(3):625-32. PubMed ID: 7647004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis.
    Attisano C; Bianchi A; Montacchini L; Carlesso N; Peola S; Bruno B; Roux V; Ferrero D; Gallo E; Boccadoro M
    Br J Haematol; 1994 Jul; 87(3):494-502. PubMed ID: 7993789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.
    Kunzmann V; Bauer E; Feurle J; Weissinger F; Tony HP; Wilhelm M
    Blood; 2000 Jul; 96(2):384-92. PubMed ID: 10887096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3 + interleukin-2 stimulation of marrow and blood: comparison of proliferation and cytotoxicity.
    Anderson PM; Ochoa AC; Ramsay NK; Hasz D; Weisdorf D
    Blood; 1992 Oct; 80(7):1846-53. PubMed ID: 1391948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
    Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
    Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
    Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
    Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).
    Resetkova E; Arreaza G; Yoshikawa N; Morita T; Kim H; Carayon P; Volpé R
    Clin Exp Immunol; 1993 Mar; 91(3):397-403. PubMed ID: 8443962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc gamma RI receptor (CD64) on autologous acute myeloid leukemic blast cells.
    Notter M; Ludwig WD; Bremer S; Thiel E
    Blood; 1993 Nov; 82(10):3113-24. PubMed ID: 7693036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.
    Janssen RA; Heijn AA; The TH; de Leij L
    Cancer Immunol Immunother; 1994 Jan; 38(1):53-60. PubMed ID: 8299119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.
    Ahmed SA; Gogal RM; Walsh JE
    J Immunol Methods; 1994 Apr; 170(2):211-24. PubMed ID: 8157999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
    Ulchaker J; Panuto J; Rayman P; Novick A; Elson P; Tubbs R; Finke JH; Bukowski RM
    J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of contaminating red blood cells on OKT3-mediated polyclonal activation of peripheral blood mononuclear cells.
    Song S; Goodwin J; Zhang J; Babbitt B; Lathey JL
    Clin Diagn Lab Immunol; 2002 May; 9(3):708-12. PubMed ID: 11986282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of monocytes and T-helper cells during development of tumor cell cytotoxicity in targeted T cells.
    Smans KA; Hoylaerts MF; De Broe ME
    Cancer Immunol Immunother; 1994 Jan; 38(1):43-52. PubMed ID: 8299118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells.
    Anderson PM; Crist W; Hasz D; Carroll AJ; Myers DE; Uckun FM
    Blood; 1992 Dec; 80(11):2826-34. PubMed ID: 1280479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells.
    Popma SH; Griswold DE; Li L
    Int Immunopharmacol; 2005 Jan; 5(1):155-62. PubMed ID: 15589476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.